Rituximab in Refractory Wegener's Granulomatosis: Favorable or Not?-Reference-Cited by-同舟云学术

Rituximab in Refractory Wegener's Granulomatosis: Favorable or Not?

Published:2006-04 Issue:7 Volume:173 Page:815a-816
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Aries Peer M.,Lamprecht Peter,Gross Wolfgang L.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference7 articles.

1. Rituximab for Refractory Wegener's Granulomatosis

2. Aries PM, Hellmich B, Both M, Nolle B, Voswinkel J, Holl-Ulrich K, Lamprecht P, Gross WL. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.Ann Rheum Dis(In press)

3. The Spectrum of Wegener's Granulomatosis and Disease Relapse

4. Anti‐CD20 therapy of treatment‐resistant Wegener's granulomatosis: favourable but temporary response

5. Is PR3-ANCA Formation Initiated in Wegener's Granulomatosis Lesions? Granulomas as Potential Lymphoid Tissue Maintaining Autoantibody Production

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort study;Clinical Otolaryngology;2009-08

2. Review article: Progress of treatment in ANCA-associated vasculitis;Nephrology;2009-02

3. Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Segunda parte: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab y cetuximab;Actas Dermo-Sifiliográficas;2008-02

4. Pathways to ANCA Production: From Differentiation of Dendritic Cells by Proteinase 3 to B Lymphocyte Maturation in Wegener’s Granuloma;Clinical Reviews in Allergy & Immunology;2008-01-08

5. Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab;Actas Dermo-Sifiliográficas (English Edition);2008